The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis
Published version of a preprint
Abstract
Purpose: Fusobacterium nucleatum (F. nucleatum) is a component of the human microbiome that primarily inhabits the oral cavity. It causes periodontal disease and has also been implicated in the development of human cancers. Although there are several reports of the relationship between F. nucleatum and the clinical outcome in human cancers, its prognostic significance in esophageal cancer remains unclear. Experimental Design: We quantified F. nucleatum DNA in 325 resected esophageal cancer specimens by qPCR. Significant pathways in F. nucleatum–positive esophageal cancer tissues were identified by Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis using microarray data. Results: Esophageal cancer tissues contained significantly more F. nucleatum DNA than matched normal esophageal mucosa (P = 0.021; n = 60). F. nucleatum DNA was detected in 74 of 325 cases (23%). F. nucleatum DNA positivity was significantly associated with tumor stage, but not with sex, age, performance status, tobacco use, alcohol use, histology, tumor location, or preoperative treatment. F. nucleatum DNA positivity was also significantly associated with cancer-specific survival [log-rank P = 0.0039; univariate HR = 2.01; 95% confidence interval (CI), 1.22–3.23; P = 0.0068; multivariate HR = 1.78; 95% CI, 1.06–2.94; P = 0.031]. The top-ranked KEGG pathway in F. nucleatum–positive tissues was “cytokine–cytokine receptor interaction.” A significant relationship between F. nucleatum and the chemokine CCL20 was validated by IHC. Conclusions: F. nucleatum in esophageal cancer tissues was associated with shorter survival, suggesting a potential role as a prognostic biomarker. F. nucleatum might also contribute to aggressive tumor behavior through activation of chemokines, such as CCL20. Clin Cancer Res; 22(22); 5574–81. ©2016 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fusobacterium spp. is important in the development and progression of gastrointestinal tumors1,19,34,35”
From RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach (2020) · cites this paper as [34]
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
The human microbiome: at the interface of health and disease
Cho, I., & Blaser, M. J. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3182 · Cited by 3,449
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Enzinger, P. C., & Mayer, R. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035010 · Cited by 2,613
Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162
Cited by
Sorted by citations
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
Brennan, C. A., & Garrett, W. S. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0129-6 · Cited by 1,205
RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach
Poore, G. D., Kopylova, E., Zhu, Q., Carpenter, C., Fraraccio, S., Wandro, S., Kosciolek, T., Janssen, S., Metcalf, J., Song, S. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2095-1 · Cited by 989
RetractedParhi, L., Alon-Maimon, T., Sol, A., Nejman, D., Shhadeh, A., Fainsod-Levi, T., Yajuk, O., Isaacson, B., Abed, J., Maalouf, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16967-2 · Cited by 716
(2023) · doi:10.1038/s41392-022-01304-4 · Cited by 460
The role of gut microbiota in cancer treatment: friend or foe?
Cheng, W. Y., Wu, C.-Y., & Yu, J. (2020) · Gut · doi:10.1136/gutjnl-2020-321153 · Cited by 384
Matson, V., Chervin, C. S., & Gajewski, T. F. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.11.041 · Cited by 385
The Oral Microbiome and Cancer
Irfan, M., Delgado, R. Z. R., & Frias-Lopez, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.591088 · Cited by 341
Bacteria in cancer initiation, promotion and progression
Tekle, G. E., & Garrett, W. S. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00594-2 · Cited by 361
The oral–gut microbiome axis in health and disease
Kunath, B. J., Rudder, C. D., Laczny, C. C., Letellier, E., & Wilmes, P. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01075-5 · Cited by 372
Unexpected guests in the tumor microenvironment: microbiome in cancer
Wong-Rolle, A., Wei, H. K., Zhao, C. N., & Jin, C. (2020) · Protein & Cell · doi:10.1007/s13238-020-00813-8 · Cited by 327
The urinary microbiome associated with bladder cancer
Bučević‐Popović, V., Šitum, M., Chow, C. T., Chan, L. S., Roje, B. M., & Terzić, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-29054-w · Cited by 299
Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer
Gao, Y., Bi, D., Xie, R., Li, M., Guo, J., Liu, H., Guo, X., Fang, J., Ding, T., Zhu, H., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00795-x · Cited by 303
The oral microbiota and its role in carcinogenesis
Stasiewicz, M., & Karpiński, T. M. M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.11.002 · Cited by 294
Intratumoural microbiota: a new frontier in cancer development and therapy
Cao, Y., Xia, H., Tan, X., Shi, C., Ma, Y., Meng, D., Zhou, M., Lv, Z., Wang, S., & Jin, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01693-0 · Cited by 269
Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified
Bruno, G., Zaccari, P., Rocco, G., Scalese, G., Panetta, C., Porowska, B., Pontone, S., & Severi, C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2706 · Cited by 258
Microbiota in Tumors: From Understanding to Application
Xie, Y., Xie, F., Zhou, X., Zhang, L., Yang, B., Huang, J., Wang, F., Yan, H., Zhang, L., Zhang, L., et al. (2022) · Advanced Science · doi:10.1002/advs.202200470 · Cited by 224
Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma
Li, M., Shao, D., Zhou, J., Gu, J., Qin, J., Chen, W., & Wei, W. (2020) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2020.06.09 · Cited by 204
Yamamura, K., Izumi, D., Kandimalla, R., Sonohara, F., Baba, Y., Yoshida, N., Kodera, Y., Baba, H., & Goel, A. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0318 · Cited by 203
Self-citationClinical and translational advances in esophageal squamous cell carcinoma
Reichenbach, Z. W., Murray, M. G., Saxena, R., Farkas, D. T., Karassik, E. G., Klochkova, A., Patel, K., Tice, C. M., Hall, T. M., Gang, J., et al. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.05.004 · Cited by 198
Fusobacterium nucleatum and oral cancer: a critical review
McIlvanna, E., Linden, G. J., Craig, S. G., Lundy, F. T., & James, J. A. (2021) · BMC Cancer · doi:10.1186/s12885-021-08903-4 · Cited by 219
Effect of probiotics and gut microbiota on anti-cancer drugs: Mechanistic perspectives
Badgeley, A., Anwar, H., Modi, K., Murphy, P., & Lakshmikuttyamma, A. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188494 · Cited by 207
Fusobacterium nucleatum and cancer
Alon‐Maimon, T., Mandelboim, O., & Bachrach, G. (2022) · Periodontology 2000 · doi:10.1111/prd.12426 · Cited by 203
Noto, J. M., & Peek, R. M. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006573 · Cited by 195
Amer, A., Galvin, S., Healy, C. M., & Moran, G. P. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02391 · Cited by 160
LaCourse, K. D., Zepeda‐Rivera, M. A., Kempchinsky, A. G., Baryiames, A. A., Minot, S. S., Johnston, C. D., & Bullman, S. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111625 · Cited by 179
Gastro-Intestinal and Oral Microbiome Signatures Associated with Healthy Aging
Singh, H., Torralba, M. G., Moncera, K. J., DiLello, L., Petrini, J., Nelson, K. E., & Pieper, R. (2019) · GeroScience · doi:10.1007/s11357-019-00098-8 · Cited by 158
Role of the oral microbiota in cancer evolution and progression
Sun, J., Tang, Q., Yu, S., Xie, M., Xie, Y., Chen, G., & Chen, L. (2020) · Cancer Medicine · doi:10.1002/cam4.3206 · Cited by 161
Shao, D., Vogtmann, E., Liu, A., Qin, J., Chen, W., Abnet, C. C., & Wei, W. (2019) · Cancer · doi:10.1002/cncr.32403 · Cited by 156
Fan, Z., Tang, P., Li, C., Yang, Q., Xu, Y., Su, C., & Li, L. (2023) · Journal of Oral Microbiology · doi:10.1080/20002297.2022.2145729 · Cited by 150
More Than Just a Periodontal Pathogen –the Research Progress on Fusobacterium nucleatum
Chen, Y., Huang, Z., Tang, Z., Huang, Y., Huang, M., Liu, H., Ziebolz, D., Schmalz, G., Jia, B., & Zhao, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.815318 · Cited by 154
Udayasuryan, B., Nguyen, T. T. D., Nguyen, T. T. D., Umaña, A., Roberts, L. M., Sobol, P., Jones, S. D., Munson, J. M., Slade, D. J., & Verbridge, S. S. (2022) · Science Signaling · doi:10.1126/scisignal.abn4948 · Cited by 152
Current understanding of the intratumoral microbiome in various tumors
Chen, X., Chu, Q., Zheng, Q., Yuan, X. H., Su, Y., Bao, Z., Lu, J., & Li, L. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100884 · Cited by 140
The microbiome and hepatobiliary-pancreatic cancers
Mima, K., Nakagawa, S., Sawayama, H., Ishimoto, T., Imai, K., Iwatsuki, M., Hashimoto, D., Baba, Y., Yamashita, Y., Yoshida, N., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.001 · Cited by 136
Self-citationLiu, Y., Baba, Y., Ishimoto, T., Tsutsuki, H., Zhang, T., Nomoto, D., Okadome, K., Yamamura, K., Harada, K., Eto, K., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01198-5 · Cited by 134
Self-citationDysbiosis of gut microbiota in patients with esophageal cancer
Deng, Y., Tang, D., Hou, P., Shen, W., Li, H., Wang, T., & Liu, R. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104709 · Cited by 133
Association of oral dysbiosis with oral cancer development (Review)
Rosa, G. R. M. L., Gattuso, G., Pedull�, E., Rapisarda, E., Nicolosi, D., & Salmeri, M. (2020) · Oncology Letters · doi:10.3892/ol.2020.11441 · Cited by 129
Review of the gut microbiome and esophageal cancer: Pathogenesis and potential clinical implications
Baba, Y., Iwatsuki, M., Yoshida, N., Watanabe, M., & Baba, H. (2017) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12014 · Cited by 123
Self-citationThe role of microbiota, and probiotics and prebiotics in skin health
Maguire, M., & Maguire, G. (2017) · Archives of Dermatological Research · doi:10.1007/s00403-017-1750-3 · Cited by 148
2019 Seoul Consensus on Esophageal Achalasia Guidelines
Jung, H., Hong, S. J., Lee, O. Y., Pandolfino, J. E., Park, H., Miwa, H., Ghoshal, U. C., Mahadeva, S., Oshima, T., Chen, M., et al. (2020) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm20014 · Cited by 120
The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management
Sun, C., Li, B., Wang, B., Zhao, J., Zhang, X., Li, T., Li, W., Tang, D., Qiu, M., Wang, X., et al. (2019) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2019.09.001 · Cited by 125
Boehm, E. T., Thon, C., Kupčinskas, J., Steponaitienė, R., Skiecevičienė, J., Canbay, A. E., Malfertheiner, P., & Link, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-73448-8 · Cited by 117
Wang, Y., Guo, H., Gao, X., & Wang, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.754788 · Cited by 121
Nomoto, D., Baba, Y., Liu, Y., Tsutsuki, H., Okadome, K., Harada, K., Ishimoto, T., Iwatsuki, M., Iwagami, S., Miyamoto, Y., et al. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.01.014 · Cited by 117
Self-citationBacterial Infections and Cancer: Exploring This Association And Its Implications for Cancer Patients
Yusuf, K., Sampath, V., & Umar, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043110 · Cited by 124
Fusobacteria modulate oral carcinogenesis and promote cancer progression
Harrandah, A. M., Chukkapalli, S. S., Bhattacharyya, I., Progulske‐Fox, A., & Chan, E. K. L. (2020) · Journal of Oral Microbiology · doi:10.1080/20002297.2020.1849493 · Cited by 112
Intracellular bacteria in cancer—prospects and debates
Schorr, L., Mathies, M., Elinav, E., & Puschhof, J. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00446-9 · Cited by 116
Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma
Chen, M., Lu, M., Hsieh, C., & Chen, W. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00573-x · Cited by 113
Yan, X., Liu, L., Li, H., Qin, H., & Sun, Z. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s145949 · Cited by 112
Powell, S., Vu, L., Spanos, W., & Pyeon, D. (2021) · Cancers · doi:10.3390/cancers13205206 · Cited by 98
Li, Y., Xing, S., Chen, F., Li, Q., Dou, S., Huang, Y., An, J., Liu, W., & Zhang, G. (2023) · Nature Communications · doi:10.1038/s41467-023-40987-3 · Cited by 102
Wolf, A., Moissl‐Eichinger, C., Perras, A., Koskinen, K., Tomazic, P. V., & Thurnher, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-06361-2 · Cited by 98
Shen, N., Caixàs, A., Ahlers, M., Patel, K., Gao, Z., Dutia, R., Blaser, M. J., Clemente, J. C., & Laferrère, B. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.05.038 · Cited by 94
Promising dawn in tumor microenvironment therapy: engineering oral bacteria
Wang, Z., Sun, W., Hua, R., Wang, Y., Li, Y., & Zhang, H. (2024) · International Journal of Oral Science · doi:10.1038/s41368-024-00282-3 · Cited by 97
Tumor Targeting by Fusobacterium nucleatum: A Pilot Study and Future Perspectives
Abed, J., Maalouf, N., Parhi, L., Chaushu, S., Mandelboim, O., & Bachrach, G. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00295 · Cited by 93
Human antimicrobial peptides and cancer
Jin, G., & Weinberg, A. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.04.006 · Cited by 92
Zhang, J., Zhang, D., Yin, H., Zhang, H., Hong, K., Yuan, J., & Yu, B. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2197836 · Cited by 97
The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
Smet, A., Kupčinskas, J., Link, A., Hold, G. L., & Bornschein, J. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.013 · Cited by 87
Pignatelli, P., Romei, F. M., Bondi, D., Giuliani, M., Piattelli, A., & Curia, M. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158323 · Cited by 90
Sakamoto, Y., Mima, K., Ishimoto, T., Ogata, Y., Imai, K., Miyamoto, Y., Akiyama, T., Daitoku, N., Hiyoshi, Y., Iwatsuki, M., et al. (2021) · Cancer Science · doi:10.1111/cas.15126 · Cited by 85
Self-citationIntratumor microbiome in cancer progression: current developments, challenges and future trends
Liu, J., & Zhang, Y. (2022) · Biomarker Research · doi:10.1186/s40364-022-00381-5 · Cited by 83
Gut microbiome in gastrointestinal cancer: a friend or foe?
Liu, Y., Baba, Y., Ishimoto, T., Gu, X. J., Zhang, J., Nomoto, D., Okadome, K., Baba, H., & Qiu, P. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.69331 · Cited by 82
Self-citationMima, K., Ogino, S., Nakagawa, S., Sawayama, H., Kinoshita, K., Krashima, R., Ishimoto, T., Imai, K., Iwatsuki, M., Hashimoto, D., et al. (2017) · Surgical Oncology · doi:10.1016/j.suronc.2017.07.011 · Cited by 80
Self-citationEmerging Insights into the Esophageal Microbiome
May, M. S., & Abrams, J. A. (2018) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-018-0171-5 · Cited by 80
Vergara, D., Simeone, P., Damato, M., Maffia, M., Lanuti, P., & Trerotola, M. (2019) · Journal of Oncology · doi:10.1155/2019/1253727 · Cited by 79
Different frequencies of Porphyromonas gingivalis infection in cancers of the upper digestive tract
Yuan, X., Liu, Y., Kong, J., Gu, B., Qi, Y., Wang, X., Sun, M., Chen, P., Sun, W., Wang, H., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.003 · Cited by 75
Fujiwara, N., Kitamura, N., Yoshida, K., Yamamoto, T., Ozaki, K., & Kudo, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176207 · Cited by 73
Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis
Huh, J., & Roh, T. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01887-4 · Cited by 80
Fusobacterium nucleatum predicts a high risk of metastasis for esophageal squamous cell carcinoma
Shi, C., Li, Z., Zheng, J., 孔为民, Fan, T., Jian, D., Cheng, X., Zhao, H., Ma, J., Tang, H., et al. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02352-6 · Cited by 74
Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance
Ye, C., Liu, X., Liu, Z., Pan, C., Zhang, X., Zhao, Z., & Sun, H. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2306676 · Cited by 76
The Role of the Microbiome in the Etiopathogenesis of Colon Cancer
Tekle, G. E., Andreeva, N., & Garrett, W. S. (2024) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042022-025619 · Cited by 78
Sharma, T., Gupta, A., Chauhan, R., Bhat, A. A., Nisar, S., Hashem, S., Akhtar, S., Ahmad, A., Haris, M., Singh, M., et al. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10026-6 · Cited by 71
Guo, S., Chen, F., Li, L., Dou, S., Li, Q., Huang, Y., Li, Z., Liu, W., & Zhang, G. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.08.014 · Cited by 67
The oncogenic roles of bacterial infections in development of cancer
Eyvazi, S., Vostakolaei, M. A., Dilmaghani, A., Borumandi, O., Hejazi, M. S., Kahroba, H., & Tarhriz, V. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104019 · Cited by 68
Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma
Yang, W., Chen, C., Jia, M., Xing, X., Gao, L., Tsai, H., Zhang, Z., Liu, Z., Zeng, B., Yeung, S. J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641270 · Cited by 67
Li, D., He, R., Hou, G., Ming, W., Fan, T. T., Chen, L., Zhang, L., Jiang, W., Wang, W., Lu, Z., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00268 · Cited by 65
Broadening oncological boundaries: the intratumoral microbiota
Lu, Y.-Q., Qiao, H., Tan, X.-R., & Liu, N. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2024.01.007 · Cited by 66
Exploring Esophageal Microbiomes in Esophageal Diseases: A Systematic Review
Park, C. H., & Lee, S. K. (2020) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm19240 · Cited by 64
Fusobacterium nucleatum CbpF Mediates Inhibition of T Cell Function Through CEACAM1 Activation
Galaski, J., Shhadeh, A., Umaña, A., Yoo, C. C., Arpinati, L., Isaacson, B., Berhani, O., Singer, B. B., Slade, D. J., Bachrach, G., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.692544 · Cited by 63
Human Gut Microbiota in Health and Selected Cancers
Sędzikowska, A., & Szablewski, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413440 · Cited by 71
Nie, F., Zhang, J., Tian, H., Zhao, J., Gong, P., Wang, H., Wang, S., Yang, P., & Yang, C. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06640-7 · Cited by 68
The effect of periodontal bacteria infection on incidence and prognosis of cancer
Li, X., Zhang, Q., Peng, Y., Wang, D., & Liu, Y. (2020) · Medicine · doi:10.1097/md.0000000000019698 · Cited by 66
Tumor-Associated Microbiome: Where Do We Stand?
Oliva, M., Mulet-Margalef, N., Ochoa-de-Olza, M., Napoli, S., Mas-Lloret, J., Laquente, B., Alemany, L., Duell, E. J., Nuciforo, P. G., & Moreno, V. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031446 · Cited by 63
Fusobacterium nucleatum: ecology, pathogenesis and clinical implications
Jiang, S., Chen, Y., & Fang, J. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-025-01237-z · Cited by 76
Lee, J. A., Yoo, S.-Y., Oh, H. J., Jeong, S., Cho, N.-Y., Kang, G. H., & Kim, J. H. (2021) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-020-02657-x · Cited by 61
The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment
Gao, F., Yu, B., Rao, B., Sun, Y. H., Yu, J., Wang, D., Cui, G., & Ren, Z. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1051987 · Cited by 63
Pignatelli, P., Iezzi, L., Pennese, M., Raimondi, P., Cichella, A., Bondi, D., Grande, R., Cotellese, R., Bartolomeo, N. D., Innocenti, P., et al. (2021) · Cancers · doi:10.3390/cancers13051032 · Cited by 59
Crosstalk between autophagy and microbiota in cancer progression
Wang, Y., Du, J., Wu, X., Abdelrehem, A., Ren, Y., Liu, C., Zhou, X., & Wang, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01461-0 · Cited by 61
Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics
Peng, F., Hu, M., Su, Z., Hu, L., Guo, L., & Yang, K. (2024) · Advanced Materials · doi:10.1002/adma.202405331 · Cited by 57
Zhang, W., Wang, S., Wang, H., Tang, Y.-J., Tang, Y., & Liang, X. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111634 · Cited by 57
The relationship between gastrointestinal cancers and the microbiota
LaCourse, K. D., Johnston, C. D., & Bullman, S. (2021) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(20)30362-9 · Cited by 58
Shao, W., Fujiwara, N., Mouri, Y., Kisoda, S., Yoshida, K., Yoshida, K., Yumoto, H., Ozaki, K., Ishimaru, N., & Kudo, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-94384-1 · Cited by 58
Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets
Dai, J.-H., Tan, X.-R., Qiao, H., & Liu, N. (2023) · Protein & Cell · doi:10.1093/procel/pwad052 · Cited by 57
Cao, C., Yue, S., Lü, A., & Liang, C. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107321 · Cited by 64
RNA landscape of the emerging cancer-associated microbe Fusobacterium nucleatum
Ponath, F., Tawk, C., Zhu, Y., Barquist, L., Faber, F., & Vogel, J. (2021) · Nature Microbiology · doi:10.1038/s41564-021-00927-7 · Cited by 53
Biofilm and Cancer: Interactions and Future Directions for Cancer Therapy
Choi, E., Murray, B., & Choi, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612836 · Cited by 53
Intratumoral bacteria are an important “accomplice” in tumor development and metastasis
Wang, G., He, X., & Wang, Q. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188846 · Cited by 51
Mima, K., Kosumi, K., Baba, Y., Hamada, T., Baba, H., & Ogino, S. (2020) · Human Genetics · doi:10.1007/s00439-020-02235-2 · Cited by 51
Self-citationJiang, S., Ma, W., Ma, C., Zhang, Z., Zhang, W., & Zhang, J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2341717 · Cited by 52
Jiang, Z., Wang, J., Shen, Z., Zhang, Z., & Wang, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.774330 · Cited by 50
Zhao, F., An, R., Ma, Y., Yu, S., Gao, Y., Wang, Y., Yu, H., Xie, X., & Zhang, J. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70273 · Cited by 50
Metadata
- Authors
- Yamamura, K., Baba, Y., Nakagawa, S., Mima, K., Miyake, K., Nakamura, K., Sawayama, H., Kinoshita, K., Ishimoto, T., Iwatsuki, M., Sakamoto, Y., Yamashita, Y., Yoshida, N., Watanabe, M., & Baba, H.
- Affiliations
- Kumamoto University (JP)
- 1Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
- The Cancer Institute Hospital (JP)
- ORCID
- Venue
- Clinical Cancer Research
- Published
- 2016-11-14
- Volume
- 22
- Issue
- 22
- Pages
- 5574-5581
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2537571631
- Cited by
- 457
- References
- 50
- Citations by year
- 2026: 33 · 2025: 68 · 2024: 70 · 2023: 60 · 2022: 51 · 2021: 69 · 2020: 54 · 2019: 24 · 2018: 11 · 2017: 16
- FWCI
- 18.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- Fusobacterium nucleatum, esophageal cancer, gut microbiota, prognostic factors, cancer-specific survival, tumor stage, CCL20, cytokine-cytokine receptor interaction, chemokines, tumor microenvironment, periodontal disease
- MeSH terms
- Aged, DNA, Bacterial, Esophageal Neoplasms, Female, Humans, Male, Prognosis, Fusobacterium nucleatum, Chemokines, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
